We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$23.6B
AUM Growth
+$2.94B
Cap. Flow
+$1.39B
Cap. Flow %
5.9%
Top 10 Hldgs %
25.86%
Holding
1,550
New
35
Increased
606
Reduced
400
Closed
47

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$126M
2
MSFT icon
Microsoft
MSFT
+$121M
3
NVDA icon
NVIDIA
NVDA
+$90.9M
4
LIN icon
Linde
LIN
+$69.5M
5
UNH icon
UnitedHealth
UNH
+$61.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63M
2
MRK icon
Merck
MRK
+$56.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$52.5M
4
ABBV icon
AbbVie
ABBV
+$49.3M
5
LLY icon
Eli Lilly
LLY
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 31.14%
2 Healthcare 18.83%
3 Financials 12.34%
4 Consumer Discretionary 9.93%
5 Consumer Staples 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATI
726
DELISTED
National Instruments Corp
NATI
$938K ﹤0.01%
+17,897
New +$898K
ELS icon
727
Equity Lifestyle Properties
ELS
$12.7B
$926K ﹤0.01%
13,798
-20,206
-59% -$1.37M
AES icon
728
AES
AES
$10.6B
$893K ﹤0.01%
37,089
IPAR icon
729
Interparfums
IPAR
$4.02B
$879K ﹤0.01%
6,179
+148
+2% +$18.2K
CHCT
730
Community Healthcare Trust
CHCT
$530M
$842K ﹤0.01%
23,010
+6,578
+40% +$257K
SCCO icon
731
Southern Copper
SCCO
$145B
$842K ﹤0.01%
11,907
-3,185
-21% -$216K
LEGN icon
732
Legend Biotech
LEGN
$3.69B
$837K ﹤0.01%
17,351
-1,200
-6% -$58.7K
AGNC icon
733
AGNC Investment
AGNC
$12.7B
$803K ﹤0.01%
79,671
-68,446
-46% -$744K
CLVT icon
734
Clarivate
CLVT
$1.29B
$798K ﹤0.01%
84,959
+64,351
+312% +$663K
PSEC icon
735
Prospect Capital
PSEC
$1.08B
$791K ﹤0.01%
113,593
-13,438
-11% -$97.6K
IJH icon
736
iShares Core S&P Mid-Cap ETF
IJH
$122B
$775K ﹤0.01%
15,500
OLED icon
737
Universal Display
OLED
$3.76B
$732K ﹤0.01%
4,718
+2,960
+168% +$398K
LI icon
738
Li Auto
LI
$13.3B
$731K ﹤0.01%
29,297
-119,028
-80% -$2.81M
DOX icon
739
Amdocs
DOX
$5.87B
$729K ﹤0.01%
+7,593
New +$703K
MED icon
740
Medifast
MED
$110M
$722K ﹤0.01%
6,968
+4,639
+199% +$514K
BLNK icon
741
Blink Charging
BLNK
$70.4M
$710K ﹤0.01%
82,106
+42,934
+110% +$453K
LPX icon
742
Louisiana-Pacific
LPX
$5.02B
$697K ﹤0.01%
12,862
+350
+3% +$21.4K
WTFC icon
743
Wintrust Financial
WTFC
$10.8B
$688K ﹤0.01%
9,436
+2,441
+35% +$209K
DT icon
744
Dynatrace
DT
$12.8B
$687K ﹤0.01%
16,241
+2,880
+22% +$117K
SEM
745
DELISTED
Select Medical
SEM
$685K ﹤0.01%
49,201
-1,074
-2% -$15.8K
NWL icon
746
Newell Brands
NWL
$2.18B
$679K ﹤0.01%
54,590
+1,031
+2% +$14.5K
XPEV icon
747
XPeng
XPEV
$12.4B
$677K ﹤0.01%
60,946
OTTR icon
748
Otter Tail
OTTR
$3.75B
$670K ﹤0.01%
9,270
+705
+8% +$46.8K
PZZA icon
749
Papa John's
PZZA
$995M
$670K ﹤0.01%
8,942
+211
+2% +$17.9K
TAL icon
750
TAL Education Group
TAL
$6.85B
$659K ﹤0.01%
102,781
+74,601
+265% +$537K

Similar funds

KBC Group's Q1 2023 Portfolio in Review

As of Q1 2023, KBC Group held 1,550 positions worth $23.6B, up 14% from $20.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

KBC Group deployed $1.39B of net new capital in Q1 2023, opening 35 new positions and adding to 606 existing holdings. Its largest new stake was GE HealthCare: 117,988 shares worth $9.68M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $63M trimmed.

  • KBC Group's largest Q1 2023 buy was GE HealthCare: 117,988 shares worth $9.68M.
  • KBC Group added most to Amazon in Q1 2023, an estimated $126M increase.
  • KBC Group's biggest Q1 2023 reduction was Apple, cutting an estimated $63M.
  • KBC Group fully exited Ingredion in Q1 2023, selling an estimated $4.04M.
  • KBC Group's ten largest holdings make up 26% of its $23.6B portfolio in Q1 2023.
  • KBC Group opened 35 new positions and closed 47 in Q1 2023.
  • KBC Group's portfolio value rose 14% quarter-over-quarter to $23.6B.

Based on KBC Group's 13F filing for Q1 2023, filed 4 May 2023.